Abbott launches SimpleScreen™ CRC blood test, joining Cologuard Plus® in its colorectal cancer screening portfolio
Only Abbott offers a complete screening solution combining end-to-end support with both stool- and blood-based colorectal cancer screening options, giving healthcare providers more ways to help eligible patients get screened1-3 SimpleScreen CRC expands screening options for adults age 45...
Covered in this story
What has happened since
- California Resources Corp is up 4.3% since this was published, 22 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on California Resources Corp
- UBS: $53.7 → $68 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on California Resources Corp →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.